1. |
国家卫生健康委员会医政司, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范 (2023版). 消化肿瘤杂志 (电子版), 2023, 15(03): 177-206.
|
2. |
Wang R, Lian J, Wang X, et al. Survival rate of colorectal cancer in China: a systematic review and meta-analysis. Front Oncol, 2023, 13: 1033154. doi: 10.3389/fonc.2023.1033154.
|
3. |
Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA, 2021, 325(7): 669-685.
|
4. |
Mun JY, Kim JE, Yoo N, et al. Survival outcomes after elective or emergency surgery for synchronous stage Ⅳ colorectal cancer. Biomedicines, 2022, 10(12): 3114. doi: 10.3390/biomedicines10123114.
|
5. |
Wang X, Mao M, Xu G, et al. The incidence, associated factors, and predictive nomogram for early death in stage Ⅳ colorectal cancer. Int J Colorectal Dis, 2019, 34(7): 1189-1201.
|
6. |
杨奕. Ⅳ期胃癌早期死亡危险因素分析及预测模型建立. 苏州大学, 2021.
|
7. |
王磊, 韩晖琼, 秦艳茹. 基于SEER数据库的转移性结肠癌患者早期死亡预测列线图模型构建. 肿瘤防治研究, 2023, 50(2): 126-131.
|
8. |
黄甫达, 许佐明, 覃忠卫. Ⅳ期结直肠癌的治疗研究进展. 癌症进展, 2022, 20(10): 977-980.
|
9. |
Hernandez Dominguez O, Yilmaz S, Steele SR. Stage Ⅳ colorectal cancer management and treatment. J Clin Med, 2023, 12(5): 2072. doi: 10.3390/jcm12052072.
|
10. |
陈树斌. 基于SEER数据库的转移性食管癌早期死亡预测列线图的构建. 汕头大学, 2021.
|
11. |
俞洋丽, 郝志敏. 老年上皮性卵巢癌患者早期死亡预测模型的构建与验证. 现代妇产科进展, 2023, 32(7): 522-528.
|
12. |
Chen K, Collins G, Wang H, et al. Pathological features and prognostication in colorectal cancer. Curr Oncol, 2021, 28(6): 5356-5383.
|
13. |
Cheong JY, Vu JV, Connelly TM, et al. The impact of race and socioeconomic status on stage Ⅳ colorectal cancer survival. Am J Surg, 2023, 225(3): 523-526.
|
14. |
刘代江, 蒋俊艳, 万晓强, 等. 结直肠癌肝转移患者生存状况及预后影响因素分析. 中华消化病与影像杂志(电子版), 2023, 13(5): 284-288.
|
15. |
Chen F, Wang F, Bailey CE, et al. Evaluation of determinants for age disparities in the survival improvement of colon cancer: results from a cohort of more than 486,000 patients in the United States. Am J Cancer Res, 2020, 10(10): 3395-3405.
|
16. |
Feliu J, Heredia-Soto V, Gironés R, et al. Can we avoid the toxicity of chemotherapy in elderly cancer patients? Crit Rev Oncol Hematol, 2018, 131: 16-23.
|
17. |
徐洪丽, 胡俊杰, 徐慧婷, 等. 不同原发部位结肠癌的临床病理及预后分析. 肿瘤防治研究, 2018, 45(9): 672-675.
|
18. |
Diez-Alonso M, Mendoza-Moreno F, Ortega MA, et al. Differences in colorectal cancer survival based on primary tumor location: retrospective study from a single institution. J Cancer, 2023, 14(13): 2444-2454.
|
19. |
黄家乐. 立体定向放疗治疗结直肠癌肝、肺转移疗效及安全性的真实世界研究. 南昌大学医学部, 2023.
|
20. |
Tirendi S, Marengo B, Domenicotti C, et al. Colorectal cancer and therapy response: a focus on the main mechanisms involved. Front Oncol, 2023, 13: 1208140. doi: 10.3389/fonc.2023.1208140.
|
21. |
Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer, 2019, 125(23): 4139-4147.
|
22. |
Morris VK, Kennedy EB, Baxter NN, et al. Treatment of metastatic colorectal cancer: ASCO Guideline. J Clin Oncol, 2023, 41(3): 678-700.
|
23. |
李瑞华, 韩正全. 结直肠癌的免疫及靶向治疗研究进展. 齐齐哈尔医学院学报, 2023, 44(10): 979-983.
|
24. |
Ciardiello F, Ciardiello D, Martini G, et al. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin, 2022, 72(4): 372-401.
|
25. |
董德嘉, 吴伟, 豆发福. Ⅳ期结直肠癌不同手术策略对患者预后的影响. 中华结直肠疾病电子杂志, 2020, 9(2): 162-168.
|
26. |
Ho MF, Lai VC, Ng DCK, et al. Prognosis of patients with unresectable stage Ⅳ colon cancer undergoing primary tumor resection: a multicenter study of minimally symptomatic or asymptomatic primary tumor. Asian J Surg, 2023, 46(9): 3710-3715.
|
27. |
Boudjema K, Locher C, Sabbagh C, et al. Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized, controlled trial. Ann Surg, 2021, 273(1): 49-56.
|